Acute Intermittent Porphyria clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Longitudinal Study of the Porphyrias
Sorry, not currently recruiting here
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.
Los Angeles, California and other locations
Our lead scientists for Acute Intermittent Porphyria research studies include Simon Beaven, MD, PhD.
Last updated: